An observational study in EEG Sleep Spindles, Motor Outcome and Cerebral Palsy, sponsored by IRCCS Fondazione Stella Maris. Enrolling by invitation at 3 sites in Italy. Open to participants aged 2 Months to 5 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-13.
Sponsored by IRCCS Fondazione Stella Maris · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris — 10 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · IRCCS Fondazione Stella Maris.
Among the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, this one is one of 3 that started in 2023, is one of 8 observational ones, and was the 8th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →10 of the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris are open now, in 2 countries. Recruiting first, the newest first:
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 7–25 · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 11–40 · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 4–18
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 6–21 · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 5–15 · Healthy volunteers
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 2 Months to 5 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 80 is above the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Median enrollment 57 across the 8 interventional studies, 80 across the 8 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Fondazione Stella Maris is the lead sponsor of 46 studies on the registry; 27 are open to participants now.
4 of the studies in Cerebral Palsy by IRCCS Fondazione Stella Maris that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07793032IRCCS Fondazione Stella MarisExperimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population | 2026-11-30 |
| NCT06288971IRCCS Fondazione Stella MarisPersonalized Innovative Intervention Pathways to Promote EF in Children With CP | 2027-01-31 |
| NCT07369193IRCCS Fondazione Stella MarisImmersive AOT: Multisensory Stimulation and Neurophysiological Correlates in Children With Cerebral Palsy and Typical Development - A Pilot Study | 2027-06 |
| NCT07369167IRCCS Fondazione Stella MarisNeural Correlates of Goal-directed Action Observation and Execution in Children With Unilateral Cerebral Palsy | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to test the effectiveness of quantitative early biomarkers in the sleep electroencephalogram (EEG), namely sleep spindles, as predictors of early sensorimotor maturation and long-term motor outcome. Spindles are discrete events, prominent over sensorimotor areas, that reflect motor learning overnight consolidation. They represent a potential marker for the investigation of altered early sensorimotor reorganization and long-term motor outcomes in the case of neuromotor pathologies. To test this hypothesis, we will validate the prognostic accuracy of a semi-automated EEG sleep-spindles analysis in two clinical populations: 1) infants with a perinatal brain lesion, at risk of Cerebral Palsy (CP), 2) infants with Spinal muscular atrophy type 1 (SMA1), a neuromuscular disease detectable at birth with variable response to early pharmacological treatment. A group of typically developing infants (at very low neurological risk) will be enrolled in the study as control group. All participants will undergo two sleep EEG recordings at 2-5 months (T1) and 12 months (T2), respectively. Short-term neuromotor outcome will be evaluated at T1 and T2, through standard and validated assessment. Long-term neuromotor development will be defined at 18 months (T3; i.e. CP vs NO CP; SMA treatment responders vs No responders). Primary clinical and motor outcomes will be used for estimating the effectiveness of spindles' features at T1 and T2 as predictors of later clinical and motor outcomes at T3. EEG sleep features will be considered both cross-sectionally, at each time point (T1, and T2), and from a longitudinal perspective. Differences in the EEG sleep-spindle features will be evaluated within- and between-groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria (apply all groups):
N= 20, Infants at risk of Unilateral Cerebral Palsy (UCP); N= 20, Infants at risk of Bilateral Cerebral Palsy (BCP).
N=20, Infants with a diagnosis of SMA type 1.
N=20, Infants born preterm or at term in absence of perinatal neurological complications, therefore a very low neurodevelopmental risk.
Clinical dichotomous outcome
For infants with perinatal brain damage, the primary outcome will be the diagnosis of CP: CP-YES vs CP-NO. For infants with SMA, the primary outcome will be the response to treatment: responders (SMA-R) vs non-responders (SMA-NR).
Time frame: 18 (+/- 3) months
Sleep EEG (T1,T2) - quantitative sleep spindles analysis
Primary predictive measure of the study
Time frame: 2-5 months, 12 (+/- 1) months
General Movements Assessment (GMA; T1)
Short-term motor outcome
Time frame: 2-5 months
Peabody Developmental Motor Scale (PDMS-II; T2 and T3)
Long-term motor outcome
Time frame: 12 (+/- 1) months, 18 (+/- 3) months
Hammersmith Infant Neurological Examination (HINE; T1, T2 and T3)
Clinical short- and long-term outcome
Time frame: 2-5 months, 12 (+/- 1) months, 18 (+/- 3) months
Started Nov 2023 (actual). Primary completion is estimated for Feb 2026, 27 months after the start.
Of 217 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 27 months is above that.
Counting every sponsor, half of 221 studies reached it within 21 months; a quarter within 8 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Fondazione Stella Maris